Search

Abigail Louise Vanhorn

Examiner (ID: 16074)

Most Active Art Unit
1616
Art Unit(s)
1616, 1609, 1636
Total Applications
1398
Issued Applications
583
Pending Applications
147
Abandoned Applications
713

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18675553 [patent_doc_number] => 20230313161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/153490 [patent_app_country] => US [patent_app_date] => 2023-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153490 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/153490
DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF Jan 11, 2023 Pending
Array ( [id] => 19297414 [patent_doc_number] => 20240225979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => COMPOSITIONS, FORMULATIONS, AND METHODS FOR HAIR TREATMENT [patent_app_type] => utility [patent_app_number] => 18/092517 [patent_app_country] => US [patent_app_date] => 2023-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17821 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18092517 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/092517
Compositions, formulations, and methods for hair treatment Jan 2, 2023 Issued
Array ( [id] => 18784661 [patent_doc_number] => 20230372254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => FORTIFIED MICRONUTRIENT SALT FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/067541 [patent_app_country] => US [patent_app_date] => 2022-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18067541 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/067541
FORTIFIED MICRONUTRIENT SALT FORMULATIONS Dec 15, 2022 Abandoned
Array ( [id] => 18451922 [patent_doc_number] => 20230193201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => METHODS FOR PRODUCING IMMUNE CELL CULTURES [patent_app_type] => utility [patent_app_number] => 18/063982 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063982 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/063982
METHODS FOR PRODUCING IMMUNE CELL CULTURES Dec 8, 2022 Pending
Array ( [id] => 18451922 [patent_doc_number] => 20230193201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => METHODS FOR PRODUCING IMMUNE CELL CULTURES [patent_app_type] => utility [patent_app_number] => 18/063982 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063982 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/063982
METHODS FOR PRODUCING IMMUNE CELL CULTURES Dec 8, 2022 Pending
Array ( [id] => 18451922 [patent_doc_number] => 20230193201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => METHODS FOR PRODUCING IMMUNE CELL CULTURES [patent_app_type] => utility [patent_app_number] => 18/063982 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063982 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/063982
METHODS FOR PRODUCING IMMUNE CELL CULTURES Dec 8, 2022 Pending
Array ( [id] => 18404439 [patent_doc_number] => 20230165789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE [patent_app_type] => utility [patent_app_number] => 18/076023 [patent_app_country] => US [patent_app_date] => 2022-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20822 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076023 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/076023
IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE Dec 5, 2022 Pending
Array ( [id] => 18389920 [patent_doc_number] => 20230158138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/058513 [patent_app_country] => US [patent_app_date] => 2022-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058513 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/058513
MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME Nov 22, 2022 Pending
Array ( [id] => 18266178 [patent_doc_number] => 20230087420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => CARBON DOTS FOR DIAGNOSTIC ANALYSIS AND DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 17/992783 [patent_app_country] => US [patent_app_date] => 2022-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992783 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/992783
CARBON DOTS FOR DIAGNOSTIC ANALYSIS AND DRUG DELIVERY Nov 21, 2022 Abandoned
Array ( [id] => 18522887 [patent_doc_number] => 20230233536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA [patent_app_type] => utility [patent_app_number] => 18/053865 [patent_app_country] => US [patent_app_date] => 2022-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13796 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053865 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/053865
Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria Nov 8, 2022 Issued
Array ( [id] => 18583177 [patent_doc_number] => 20230265437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use [patent_app_type] => utility [patent_app_number] => 18/048577 [patent_app_country] => US [patent_app_date] => 2022-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44045 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048577 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/048577
RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use Oct 20, 2022 Pending
Array ( [id] => 18449387 [patent_doc_number] => 20230190663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/950573 [patent_app_country] => US [patent_app_date] => 2022-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/950573
PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF Sep 21, 2022 Pending
Array ( [id] => 18449387 [patent_doc_number] => 20230190663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/950573 [patent_app_country] => US [patent_app_date] => 2022-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/950573
PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF Sep 21, 2022 Pending
Array ( [id] => 18581656 [patent_doc_number] => 20230263910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => AAV VECTORS TARGETED TO THE CENTRAL NERVOUS SYSTEM [patent_app_type] => utility [patent_app_number] => 17/933937 [patent_app_country] => US [patent_app_date] => 2022-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34787 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17933937 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/933937
AAV VECTORS TARGETED TO THE CENTRAL NERVOUS SYSTEM Sep 20, 2022 Pending
Array ( [id] => 19195361 [patent_doc_number] => 11992580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-28 [patent_title] => Method of soft tissue augmentation [patent_app_type] => utility [patent_app_number] => 17/941713 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5379 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941713 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/941713
Method of soft tissue augmentation Sep 8, 2022 Issued
Array ( [id] => 19792365 [patent_doc_number] => 12233289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-25 [patent_title] => Methods for fixing hair and skin [patent_app_type] => utility [patent_app_number] => 17/941675 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15183 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941675 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/941675
Methods for fixing hair and skin Sep 8, 2022 Issued
Array ( [id] => 18550883 [patent_doc_number] => 20230248884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => COMPOSITIONS AND METHODS FOR MODULATING WOUND HEALING AND REGENERATION [patent_app_type] => utility [patent_app_number] => 17/929886 [patent_app_country] => US [patent_app_date] => 2022-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/929886
COMPOSITIONS AND METHODS FOR MODULATING WOUND HEALING AND REGENERATION Sep 5, 2022 Abandoned
Array ( [id] => 18107994 [patent_doc_number] => 20230000874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => PEMETREXED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/898558 [patent_app_country] => US [patent_app_date] => 2022-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9330 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898558 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/898558
PEMETREXED FORMULATIONS Aug 29, 2022 Abandoned
Array ( [id] => 18091282 [patent_doc_number] => 20220409623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => PEMETREXED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/898637 [patent_app_country] => US [patent_app_date] => 2022-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9335 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898637 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/898637
PEMETREXED FORMULATIONS Aug 29, 2022 Abandoned
Array ( [id] => 18091283 [patent_doc_number] => 20220409624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => PEMETREXED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/898984 [patent_app_country] => US [patent_app_date] => 2022-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9330 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898984 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/898984
PEMETREXED FORMULATIONS Aug 29, 2022 Abandoned
Menu